Psychological impact of breast cancer screening in Japan
Psychological impact of breast cancer screening in Japan
复制标题
DOI：
10.1007/s10147-015-0845-0
复制
发表时间：
2015-12-01
影响因子：
3.3
通讯作者：
Tsunoda, Hiroko
中科院分区：
文献类型：
--
作者：
Kitano, Atsuko;Yamauchi, Hideko;Tsunoda, Hiroko
本研究的目的是评估使用乳房 X 光检查和/或超声波进行乳腺癌筛查的心理影响，并揭示与心理困扰相关的因素。2012 年 3 月至 11 月期间，320 名女性因乳腺癌筛查发现可疑恶性结果而被召回我们医院。她们被要求填写三份问卷：针对焦虑和抑郁的医院焦虑和抑郁量表 (HADS)，针对焦虑和抑郁的简要应对问题取向量表 (Brief COPE)。应对方式以及个人信息原始调查问卷。320 名女性中的 312 名 (97.5%) 可获得完整数据。中位年龄为 45 岁（范围 23-73 岁）。 HADS 显示 70% 的女性处于边缘或临床显着焦虑状态。乳腺癌家族史、居住地区、筛查次数、回忆次数以及首次就诊前的时间段与心理困扰显着相关（p < 0.05）。简短的 COPE 评分显示，自责、行为脱离、自我分心、使用情感支持、发泄、否认和较少接受与焦虑增加有关。乳腺癌筛查后回忆的女性中有 70% 经历过心理困扰。因此，负面的心理影响应被视为乳腺癌筛查的不利影响。
The purpose of this study was to evaluate the psychological impact of breast cancer screening by use of mammography and/or ultrasound, and to reveal factors related to psychological distress.Three hundred and twenty women were recalled to our hospital because of suspicious malignant findings from breast cancer screening between March and November 2012. They were asked to complete three questionnaires: the Hospital Anxiety and Depression Scale (HADS) for anxiety and depression, the Brief Coping Orientations to Problems Experienced scale (Brief COPE) for coping styles, and an original questionnaire for personal information.Complete data were available for 312 of 320 women (97.5 %). The median age was 45 years (range 23-73). The HADS revealed borderline or clinically significant anxiety for 70 % of the women. Family history of breast cancer, area of residence, number of times screened, number of recalls, and the period before the first visit were significantly related to psychological distress (p < 0.05). Brief COPE scores showed that self-blame, behavioral disengagement, self-distraction, use of emotional support, venting, denial, and less acceptance were related to increased anxiety.Seventy percent of women who were recalled after breast cancer screening experienced psychological distress. Thus, negative psychological impact should be regarded as an adverse effect of breast cancer screening.